SperiousMonkey:
Do you know anything about Regeneron and this:
"Regeneron scientists have recently developed a novel high-throughput approach that is amenable to creating many preclinical disease models a year. These approaches have been grouped under the term “Velocigene,” allowing for the high throughput assignment of function to genes. Velocigene uses a proprietary and high-throughput process to ablate genes (creating gene “knockouts”) or introduce extra gene copies (creating “transgenics”), rapidly producing mammalian models for elucidating the function of the altered genes. Regeneron developed Velocigene to “functionize” the large numbers of newly identified genes resulting from the sequencing of the human genome, so as to determine rapidly which of these many genes represent validated therapeutic targets for pharmaceutical drug development."